# CCCC (C4 Therapeutics, Inc.) - SEC EDGAR Financial Statements

> C4 Therapeutics, Inc. reported $32.28M in revenue and a net loss of $91.09M for the trailing twelve months ended September 30, 2026 (down 24.6% year over year), with a -315.9% operating margin.

- Canonical: https://convexityos.com/fundamentals/CCCC
- Markdown: https://convexityos.com/fundamentals/CCCC.md
- SEC CIK: 0001662579
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:38 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001662579&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $32.28M | -24.6% YoY |
| Operating Income | TTM | -$101.9M | -315.9% margin |
| Net Income | TTM | -$91.09M | -282.2% net margin |
| Diluted EPS | TTM | -$0.67 | Split-adjusted |
| Free Cash Flow | TTM | -$79.74M | -247.1% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $32.42M | Total debt: $55.25M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $35.95M | $35.58M | $20.76M | $31.10M | $45.78M | -- | -- |
| Research & Development | $104.2M | $110.6M | $117.7M | $117.8M | $94.67M | $78.44M | $48.06M |
| Total Operating Expenses | $151.2M | $155.2M | $159.8M | $160.6M | $127.9M | $93.64M | $56.83M |
| **Operating Income** | -$115.2M | -$119.6M | -$139.0M | -$129.5M | -$82.13M | -$60.45M | -$35.45M |
| **EBITDA** | -$113.3M | -$117.8M | -$137.2M | -$127.9M | -$80.64M | -$58.83M | -$33.86M |
| Income Before Tax | -$104.9M | -$105.2M | -$131.2M | -$128.2M | -$83.89M | -$66.96M | -$33.30M |
| Income Tax Expense | $121K | $131K | $1.28M | $0 | $0 | -$626K | $804K |
| **Net Income** | -$105.0M | -$105.3M | -$132.5M | -$128.2M | -$83.89M | -$66.33M | -$34.10M |
| Basic EPS | -$1.27 | -$1.52 | -$2.67 | -$2.62 | -$1.82 | -$5.83 | -$31.03 |
| **Diluted EPS** | -$1.27 | -$1.52 | -$2.67 | -$2.62 | -$1.82 | -$5.83 | -$31.03 |
| Basic Shares Outstanding | 82.9M | 69.4M | 49.6M | 48.9M | 46.0M | 11.4M | 1.4M |
| Diluted Shares Outstanding | 82.9M | 69.4M | 49.6M | 48.9M | 46.0M | 11.4M | 1.4M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $8.47M | $6.64M | $6.15M | $11.02M | $11.23M | $6.46M | $7.24M | $5.18M |
| Research & Development | $24.80M | $24.47M | $24.61M | $24.98M | $25.99M | $26.20M | $27.07M | $32.51M |
| Total Operating Expenses | $33.06M | $33.06M | $33.94M | $34.16M | $45.64M | $34.96M | $36.40M | $42.89M |
| **Operating Income** | -$24.60M | -$26.42M | -$27.79M | -$23.14M | -$34.41M | -$28.50M | -$29.16M | -$37.71M |
| **EBITDA** | -$24.28M | -$26.13M | -$27.38M | -$22.77M | -$33.95M | -$27.89M | -$28.71M | -$37.34M |
| Income Before Tax | -- | -- | -- | -$20.36M | -$32.17M | -$26.02M | -$26.32M | -$34.44M |
| Income Tax Expense | $0 | $0 | $0 | $121K | $0 | $0 | $0 | $131K |
| **Net Income** | -$21.84M | -$23.64M | -$25.13M | -$20.49M | -$32.17M | -$26.02M | -$26.32M | -$34.57M |
| Basic EPS | -$0.16 | -$0.18 | -$0.20 | -- | -$0.44 | -$0.37 | -$0.37 | -- |
| **Diluted EPS** | -$0.16 | -$0.18 | -$0.20 | -- | -$0.44 | -$0.37 | -$0.37 | -- |
| Basic Shares Outstanding | 136.1M | 130.7M | 126.1M | -- | 72.6M | 71.0M | 70.8M | -- |
| Diluted Shares Outstanding | 136.1M | 130.7M | 126.1M | -- | 72.6M | 71.0M | 70.8M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $74.60M | $55.50M | $126.6M | $29.75M | $76.12M | $181.7M | $90.55M |
| Short-Term Investments | -- | -- | -- | -- | $233.2M | $190.0M | -- |
| **Cash & Short-Term Investments** | $297.1M | $267.3M | $281.7M | $337.1M | $451.5M | $371.7M | $90.55M |
| Accounts Receivable, Net | $2.40M | $3.10M | $11.80M | $1.47M | $5.72M | $4.48M | $4.62M |
| **Total Current Assets** | $258.1M | $257.8M | $271.2M | $287.6M | $325.7M | $381.0M | $96.77M |
| Property, Plant & Equipment, Net | $4.74M | $5.84M | $7.13M | $7.40M | $3.11M | $3.32M | $4.46M |
| Long-Term Investments | -- | -- | -- | -- | $142.2M | -- | -- |
| Other Non-Current Assets | $3.68M | $2.65M | $2.72M | $1.53M | $544K | -- | -- |
| **Total Non-Current Assets** | $101.0M | $91.83M | $105.3M | $143.3M | $181.1M | $19.13M | $21.49M |
| **Total Assets** | $359.1M | $349.6M | $376.5M | $430.8M | $506.8M | $400.1M | $118.3M |
| Accounts Payable | $858K | $1.33M | $1.45M | $1.17M | $4.51M | $5.68M | $5.38M |
| Short-Term Debt | -- | -- | $0 | $2.29M | $0 | -- | -- |
| Deferred Revenue (Current) | $12.49M | $18.71M | $15.47M | $16.62M | $31.80M | $27.60M | $20.70M |
| Other Current Liabilities | $1.40M | $1.87M | $2.04M | $3.11M | $413K | $469K | $280K |
| **Total Current Liabilities** | $33.03M | $45.18M | $42.77M | $44.55M | $51.25M | $43.85M | $33.64M |
| Long-Term Debt | -- | -- | $0 | $9.20M | $10.77M | $10.05M | -- |
| Deferred Revenue (Non-Current) | $15.84M | $28.46M | $21.81M | $16.89M | $24.37M | $53.62M | $72.72M |
| **Total Non-Current Liabilities** | $69.46M | $88.44M | $87.57M | $97.06M | $65.91M | $75.50M | $85.59M |
| **Total Liabilities** | $102.5M | $133.6M | $130.3M | $141.6M | $117.2M | $119.3M | $119.2M |
| **Total Debt (incl. Leases)** | $59.98M | $65.76M | $70.98M | $87.15M | $42.88M | $22.92M | $13.75M |
| Common Stock | $9.0K | $7.0K | $6.0K | $5.0K | $5.0K | $4.0K | $1.0K |
| Retained Earnings | -$738.7M | -$633.7M | -$528.4M | -$395.9M | -$267.7M | -$183.8M | -$117.5M |
| Accumulated Other Comp. Income | $50K | $53K | -$127K | -$4.14M | -$775K | $13K | -- |
| **Total Stockholders' Equity** | $256.6M | $216.0M | $246.1M | $289.2M | $389.6M | $280.8M | -$112.0M |
| Total Equity | $256.6M | $216.0M | $246.1M | $289.2M | $389.6M | $280.8M | -$112.0M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $32.42M | $78.61M | $61.27M | $74.60M | $58.81M | $78.16M | $51.29M | $55.50M |
| **Cash & Short-Term Investments** | $274.7M | $300.4M | $268.3M | $297.1M | $199.8M | $223.0M | $234.7M | $267.3M |
| Accounts Receivable, Net | $1.41M | $1.33M | $2.88M | $2.40M | $6.54M | $2.16M | $8.03M | $3.10M |
| **Total Current Assets** | $214.5M | $262.9M | $245.4M | $258.1M | $206.9M | $224.7M | $232.5M | $257.8M |
| Property, Plant & Equipment, Net | $3.83M | $4.15M | $4.49M | $4.74M | $5.13M | $5.54M | $5.48M | $5.84M |
| Other Non-Current Assets | $4.57M | $4.49M | $3.87M | $3.68M | $211K | $178K | $2.56M | $2.65M |
| **Total Non-Current Assets** | $117.3M | $96.50M | $83.49M | $101.0M | $58.62M | $71.80M | $86.99M | $91.83M |
| **Total Assets** | $331.8M | $359.4M | $328.9M | $359.1M | $265.5M | $296.5M | $319.5M | $349.6M |
| Accounts Payable | $963K | $1.12M | $773K | $858K | $1.33M | $2.22M | $683K | $1.33M |
| Deferred Revenue (Current) | $19.52M | $26.66M | $10.12M | $12.49M | $17.13M | $22.62M | $21.59M | $18.71M |
| Other Current Liabilities | $989K | $995K | $1.57M | $1.40M | $1.75M | $1.58M | $1.88M | $1.87M |
| **Total Current Liabilities** | $41.46M | $48.25M | $27.25M | $33.03M | $35.95M | $44.46M | $40.82M | $45.18M |
| Deferred Revenue (Non-Current) | $13.77M | $13.71M | $15.44M | $15.84M | $19.89M | $21.15M | $25.12M | $28.46M |
| **Total Non-Current Liabilities** | $62.17M | $63.89M | $67.36M | $69.46M | $75.14M | $78.01M | $83.56M | $88.44M |
| **Total Liabilities** | $103.6M | $112.1M | $94.61M | $102.5M | $111.1M | $122.5M | $124.4M | $133.6M |
| **Total Debt (incl. Leases)** | $55.25M | $56.86M | $58.45M | $59.98M | $61.46M | $62.92M | $64.37M | $65.76M |
| Common Stock | $13K | $12K | $10K | $9.0K | $7.0K | $7.0K | $7.0K | $7.0K |
| Retained Earnings | -$809.3M | -$787.5M | -$763.8M | -$738.7M | -$718.2M | -$686.0M | -$660.0M | -$633.7M |
| Accumulated Other Comp. Income | -$1.06M | -$444K | -$322K | $50K | $87K | -$30K | $43K | $53K |
| **Total Stockholders' Equity** | $228.2M | $247.3M | $234.2M | $256.6M | $154.4M | $174.1M | $195.1M | $216.0M |
| Total Equity | $228.2M | $247.3M | $234.2M | $256.6M | $154.4M | $174.1M | $195.1M | $216.0M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$105.0M | -$105.3M | -$132.5M | -$128.2M | -$83.89M | -$66.33M | -$34.10M |
| Depreciation & Amortization | $1.96M | $1.82M | $1.88M | $1.68M | $1.49M | $1.62M | $1.59M |
| Stock-Based Compensation | $19.10M | $29.66M | $27.23M | $30.02M | $21.51M | $3.43M | $1.64M |
| Change in Receivables | $701K | $8.70M | -$10.33M | $4.24M | -$1.23M | $139K | $81.81M |
| Change in Payables | -$468K | -$119K | $273K | -$3.33M | -$1.18M | $467K | $4.23M |
| **Operating Cash Flow** | -$98.69M | -$65.16M | -$106.8M | -$105.9M | -$86.97M | -$67.25M | $55.61M |
| Capital Expenditure | -$607K | -$180K | -$1.71M | -$5.50M | -$1.28M | -$650K | -$1.35M |
| **Free Cash Flow** | -$99.30M | -$65.34M | -$108.5M | -$111.4M | -$88.24M | -$67.90M | $54.27M |
| Purchases of Investments | -$227.1M | -$284.3M | -$129.9M | -$219.5M | -$537.7M | -$293.9M | -$79.00M |
| **Investing Cash Flow** | -$8.60M | -$51.27M | $158.3M | $58.42M | -$189.3M | -$190.5M | -$1.62M |
| Common Stock Issued | -- | -- | $57.67M | $0 | -- | -- | -- |
| Share Repurchases | -$193K | -$194K | -$110K | $0 | -- | -$194K | -$30K |
| **Financing Cash Flow** | $126.4M | $45.34M | $45.49M | $1.15M | $171.4M | $348.9M | $244K |
| **Net Change in Cash** | $19.10M | -$71.09M | $97.00M | -$46.37M | -$104.9M | $91.18M | $54.24M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$21.84M | -$23.64M | -$25.13M | -$20.49M | -$32.17M | -$26.02M | -$26.32M | -$34.57M |
| Depreciation & Amortization | $320K | $292K | $404K | $377K | $460K | $615K | $456K | $364K |
| Stock-Based Compensation | $2.98M | $3.04M | $2.67M | $4.01M | $4.59M | $4.99M | $5.51M | $8.23M |
| Change in Receivables | -$71K | $1.55M | -$482K | $4.14M | -$4.34M | $5.83M | -$4.93M | $7.24M |
| Change in Payables | -$158K | $348K | -$85K | -$472K | -$885K | $1.53M | -$645K | -$176K |
| **Operating Cash Flow** | -$25.97M | -$1.57M | -$29.94M | -$22.14M | -$31.21M | -$12.06M | -$33.28M | -$17.93M |
| Capital Expenditure | $0 | -$37K | -$64K | -$11K | -$411K | -$185K | $0 | $4.0K |
| **Free Cash Flow** | -$25.97M | -$1.61M | -$30.01M | -$22.16M | -$31.62M | -$12.24M | -$33.28M | -$17.93M |
| Purchases of Investments | -$68.63M | -$70.83M | -$40.81M | -$133.1M | -$46.68M | -$21.68M | -$25.64M | -$40.78M |
| **Investing Cash Flow** | -$20.58M | -$14.81M | $16.15M | -$80.73M | $4.09M | $38.92M | $29.12M | $13.67M |
| Share Repurchases | -$39K | $0 | -$200K | -$14K | -$24K | $0 | -$155K | $0 |
| **Financing Cash Flow** | $359K | $33.73M | $462K | $118.7M | $7.77M | $0 | -$46K | $112K |
| **Net Change in Cash** | -$46.19M | $17.34M | -$13.33M | $15.79M | -$19.35M | $26.86M | -$4.21M | -$4.15M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -320.5% | -336.1% | -669.8% | -416.6% | -179.4% | -- | -- |
| **Net Profit Margin** | -292.1% | -296.0% | -638.3% | -412.2% | -183.2% | -- | -- |
| Return on Equity (ROE) | -40.9% | -48.8% | -53.8% | -44.3% | -21.5% | -23.6% | -- |
| Return on Assets (ROA) | -29.2% | -30.1% | -35.2% | -29.8% | -16.6% | -16.6% | -28.8% |
| Current Ratio | 7.81x | 5.71x | 6.34x | 6.46x | 6.36x | 8.69x | 2.88x |
| Quick Ratio | 9.07x | 5.99x | 6.86x | 7.60x | 8.92x | 8.58x | 2.83x |
| Debt to Equity | 0.23x | 0.30x | 0.29x | 0.30x | 0.11x | 0.08x | -- |
| **Revenue Growth (YoY)** | +1.0% | +71.4% | -33.3% | -32.1% | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | -- | -- | -220.9% | -- |
| Free Cash Flow Growth (YoY) | -- | -- | -- | -- | -- | -225.1% | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -315.9% | -319.0% | -326.6% | -320.5% | -431.1% | -361.0% | -293.0% | -336.1% |
| **Net Profit Margin** | -282.2% | -289.4% | -297.8% | -292.1% | -395.5% | -325.9% | -259.6% | -296.0% |
| Return on Equity (ROE) | -39.9% | -41.0% | -44.3% | -40.9% | -77.1% | -64.1% | -52.9% | -48.8% |
| Return on Assets (ROA) | -27.5% | -28.2% | -31.6% | -29.2% | -44.9% | -37.6% | -32.3% | -30.1% |
| Current Ratio | 5.17x | 5.45x | 9.00x | 7.81x | 5.76x | 5.06x | 5.70x | 5.71x |
| Quick Ratio | 6.66x | 6.25x | 9.95x | 9.07x | 5.74x | 5.06x | 5.95x | 5.99x |
| Debt to Equity | 0.24x | 0.23x | 0.25x | 0.23x | 0.40x | 0.36x | 0.33x | 0.30x |
| **Revenue Growth (YoY)** | -24.6% | +2.8% | -15.0% | +112.8% | -26.9% | -46.2% | +138.2% | +58.8% |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
